Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Propanc Biopharma, Inc. PPCBD

Full chart Compare
Set alert

Price alert · PPCBD

All alert types
5.68 USD 0.00 (+0.00%)

At closeMar 26, 2025, 4:00 PM EDT

4.51 Day range 5.75
1.50 52-week range 221.56

Financial health

Altman Z-Score

-18.59 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.0×
FY 2016: -9739583×FY 2017: -0.4×FY 2018: -0.2×FY 2019: -0.3×FY 2020: -0.0×FY 2021: -3882×FY 2022: -0.2×FY 2023: -0.3×FY 2024: -0.1×FY 2025: -0.0×
FY 2016 5y median -0.2× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.1×
FY 2016: -35504073×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -0.0×FY 2021: -3060×FY 2022: -16037×FY 2023: -15640×FY 2024: -0.0×FY 2025: 0.1×
FY 2016 5y median -3060× FY 2025
P/FCF -2.1×
FY 2016: -18936192×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -0.1×FY 2021: -8196×FY 2022: -33760×FY 2023: -44111×FY 2024: -0.1×FY 2025: -2.1×
FY 2016 5y median -8196× FY 2025
EV/EBITDA -0.0×
FY 2016: -18230254×FY 2017: -0.7×FY 2018: -1.0×FY 2019: -0.3×FY 2020: -0.5×FY 2021: -5561×FY 2022: -22670×FY 2023: -21814×FY 2024: -0.8×FY 2025: -0.0×
FY 2016 5y median -5561× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -48.7%
FY 2016: -0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -1897.0%FY 2021: -0.0%FY 2022: -0.0%FY 2023: -0.0%FY 2024: -847.8%FY 2025: -48.7%
FY 2016 5y median -0.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -423.7%
FY 2016: 366.8%FY 2017: 144.6%FY 2018: 104.3%FY 2019: 133.9%FY 2020: 130.2%FY 2021: 66.0%FY 2022: 87.9%FY 2023: 85.4%FY 2024: 48.2%FY 2025: -423.7%
FY 2016 5y median 66.0% FY 2025
ROIC -366.4%
FY 2016: 463.3%FY 2017: 270.1%FY 2018: 175.4%FY 2019: 93.4%FY 2020: 158.8%FY 2021: 71.9%FY 2022: 98.4%FY 2023: 65.9%FY 2024: 50.7%FY 2025: -366.4%
FY 2016 5y median 65.9% FY 2025
ROA -300.1%
FY 2016: -2481.9%FY 2017: -8275.0%FY 2018: -9860.3%FY 2019: -5664.4%FY 2020: -4812.3%FY 2021: -15464.5%FY 2022: -3255.3%FY 2023: -4410.9%FY 2024: -2516.4%FY 2025: -300.1%
FY 2016 5y median -3255.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -3629.0%
FY 2016: -304.3%FY 2017: 16.8%FY 2018: 31.0%FY 2019: 34.0%FY 2020: -33.6%FY 2021: 48.1%FY 2022: -9.9%FY 2023: 10.7%FY 2024: 13.6%FY 2025: -3629.0%
FY 2016 FY 2025
EPS (diluted) 76.6%
FY 2016: 0.0%FY 2017: -466969373120.8%FY 2018: 84.1%FY 2019: 93.9%FY 2020: 98.2%FY 2021: 99.6%FY 2022: -140292.5%FY 2023: 97.2%FY 2024: 95.5%FY 2025: 76.6%
FY 2016 FY 2025
Free Cash Flow 56.7%
FY 2016: -236.3%FY 2017: 55.3%FY 2018: 100.0%FY 2019: 0.0%FY 2020: 10.3%FY 2021: 38.1%FY 2022: -25.4%FY 2023: 23.0%FY 2024: 15.4%FY 2025: 56.7%
FY 2016 FY 2025

Financial Health

Current Ratio 1.5×
FY 2016: 0.1×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 1.5×
FY 2016 5y median 0.0× FY 2025
Quick Ratio 1.5×
FY 2016: 0.1×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 1.5×
FY 2016 5y median 0.0× FY 2025
Debt / Equity 0.1×
FY 2016: -0.4×FY 2017: -0.6×FY 2018: -0.7×FY 2019: -0.4×FY 2020: -0.4×FY 2021: -0.2×FY 2022: -0.3×FY 2023: -0.2×FY 2024: -0.3×FY 2025: 0.1×
FY 2016 5y median -0.2× FY 2025
Net Debt / EBITDA -0.0×
FY 2016: -0.2×FY 2017: -0.7×FY 2018: -1.0×FY 2019: -0.3×FY 2020: -0.5×FY 2021: -0.4×FY 2022: -0.5×FY 2023: -0.2×FY 2024: -0.7×FY 2025: -0.0×
FY 2016 5y median -0.4× FY 2025
Interest Coverage -102×
FY 2016: -1.5×FY 2017: -1.8×FY 2018: -1.4×FY 2019: -2.0×FY 2020: -2.0×FY 2021: -4.0×FY 2022: -3.5×FY 2023: -3.3×FY 2024: -2.3×FY 2025: -102×
FY 2016 5y median -3.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-06-30